Zota Health CareNSE:ZOTA +0.44%76 Gross Margin % is 63.46% as of Mar. 2026, which is 96% above its 10-year median of 32.31. GuruFocus rates NSE:ZOTA with a GF Score™ of 76/100 and a GF Value™ of ₹1,588.32 (Fairly Valued). The stock has 3 warning signs investors should review. Among 732 Biotechnology companies, Zota Health Care ranks worse than 50.55% on this metric.
The historical rank and industry rank for Zota Health Care's Gross Margin % or its related term are showing as below:
NSE:ZOTA'
s Gross Margin % Range Over the Past 10 Years
Min: 27.93 Med: 32.31 Max: 60.28
Current: 60.28
During the past 13 years, the highestGross Margin % of Zota Health Care was 60.28%. The lowest was 27.93%. And the median was 32.31%.
NSE:ZOTA's Gross Margin % is ranked worse than 50.55% of 732
companies
in the Biotechnology industry
Industry Median: 60.91
vs NSE:ZOTA: 60.28
Zota Health Care had a gross margin of 63.46% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Zota Health Care was 16.30% per year.
Zota Health Care (NSE:ZOTA) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Zota Health Care had a gross margin of 63.46% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Zota Health Care Gross Margin % Related Terms
Zota Health Care Gross Margin % Historical Data
* Premium members only.
The historical data trend for Zota Health Care's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ZOTA vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Zota Health Care's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zota Health Care Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zota Health Care's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Zota Health Care's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Zota Health Care (NSE:ZOTA) has a Gross Margin % of 63.46% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Zota Health Care and its competitors. This is 96% above median its historical median of 32.31. Over the past decade, Zota Health Care's Gross Margin % has ranged from 27.93 to 60.28. According to the industry distribution chart, Zota Health Care ranks #370 out of 732 companies in the Biotechnology industry, placing it in the top 50.5%.
Is Zota Health Care's Gross Margin % too high?
Zota Health Care's current Gross Margin % of 63.46% is 96% above median its 10-year median of 32.31. Over the past 10 years, this metric has ranged from a low of 27.93 to a high of 60.28. The Biotechnology industry median Gross Margin % is 60.91. Zota Health Care's value of 63.46% is 4.2% above this industry median. Based on the distribution chart, Zota Health Care ranks #370 out of 732 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Zota Health Care has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zota Health Care's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Zota Health Care ranks #370 out of 732 companies for Gross Margin %. This places Zota Health Care in the lower half of its industry. The industry median Gross Margin % is 60.91. Zota Health Care's value of 63.46% is 4.2% above this benchmark. Historically, Zota Health Care's own Gross Margin % has ranged from 27.93 to 60.28 over the past decade. While the company's 10-year median is 32.31 vs. the industry median of 60.91, Zota Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zota Health Care's current Gross Margin % of 63.46% is 4.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Zota Health Care and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zota Health Care's current Gross Margin % is 63.46%, which is 96% above median its own 10-year median of 32.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zota Health Care stock overvalued right now?
Based on GuruFocus' analysis, Zota Health Care (NSE:ZOTA) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,588.32, compared to a current price of ₹1,444.90 — trading 9% below its estimated fair value. The current Gross Margin % is 63.46%, which is 96% above median its 10-year median of 32.31 and 4.2% above the Biotechnology industry median of 60.91. Zota Health Care's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Zota Health Care (NSE:ZOTA), the current Gross Margin % is 63.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zota Health Care (NSE:ZOTA) Overvalued in 2026?
Based on GuruFocus' analysis, Zota Health Care stock appears to be undervalued.
The current stock price of ₹1,444.90 is trading 9% below its estimated GF Value™ of ₹1,588.32.
GuruFocus considers Zota Health Care to be Fairly Valued.
Key valuation signals for NSE:ZOTA:
Gross Margin %: 63.46% (96% above median its 10-year median of 32.31)
GF Value™: ₹1,588.32 vs. price of ₹1,444.90 (9% below fair value)
Industry Position: 4.2% above the Biotechnology median (#370 of 732)
No single metric tells the full story. See the NSE:ZOTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zota Health Care Ltd is engaged in the manufacturing, trading, and export of pharmaceutical products. The company caters to both domestic and international markets. It offers a vast range of pharmaceutical, nutraceutical, ayurvedic, and OTC products in India and overseas as well.
76GF Score
Get the complete analysis for NSE:ZOTA
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ZOTA has been successfully added to your 
